We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
-17.67%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$666M
AUM Growth
-$78.6M
Cap. Flow
+$47.8M
Cap. Flow %
7.17%
Top 10 Hldgs %
3.73%
Holding
1,985
New
628
Increased
360
Reduced
345
Closed
644

Top Buys

Rank Stock Value
1
RLAY icon
Relay Therapeutics
RLAY
+$3.83M
2
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$3M
3
TECK icon
Teck Resources
TECK
+$2.87M
4
MODV
ModivCare
MODV
+$2.67M
5
G icon
Genpact
G
+$2.6M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$3.07M
2
CHS
Chicos FAS, Inc.
CHS
+$2.68M
3
KRE icon
State Street SPDR S&P Regional Banking ETF
KRE
+$2.45M
4
CXT icon
Crane NXT
CXT
+$2.44M
5
ATCO
Atlas Corp.
ATCO
+$2.27M

Sector Composition

Rank Sector Weight
1 Healthcare 18.12%
2 Technology 15.11%
3 Consumer Discretionary 12.76%
4 Industrials 12.53%
5 Financials 11.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVTA
126
DELISTED
Avantax, Inc. Common Stock
AVTA
$1.05M 0.16%
57,122
+34,821
+156% +$633K
BABA icon
127
Alibaba
BABA
$308B
$1.05M 0.16%
9,249
+6,980
+308% +$685K
BAC icon
128
Bank of America
BAC
$442B
$1.05M 0.16%
33,697
-3,544
-10% -$128K
UPLD icon
129
Upland Software
UPLD
$12.8M
$1.05M 0.16%
7,226
+2,151
+42% +$314K
RNAC icon
130
Cartesian Therapeutics
RNAC
$245M
$1.04M 0.16%
26,568
+21,518
+426% +$638K
IMKTA icon
131
Ingles Markets
IMKTA
$1.67B
$1.04M 0.16%
11,981
+4,652
+63% +$423K
REPL icon
132
Replimune Group
REPL
$994M
$1.04M 0.16%
59,430
-27,694
-32% -$455K
TBPH icon
133
Theravance Biopharma
TBPH
$876M
$1.04M 0.16%
114,646
+65,190
+132% +$601K
DNOW icon
134
DNOW Inc
DNOW
$2.6B
$1.04M 0.16%
+106,053
New +$1.13M
PYPL icon
135
PayPal
PYPL
$49.6B
$1.04M 0.16%
14,839
+7,888
+113% +$684K
DOX icon
136
Amdocs
DOX
$5.87B
$1.03M 0.15%
+12,352
New +$1.02M
HSTM icon
137
HealthStream
HSTM
$818M
$1.02M 0.15%
46,883
-13,457
-22% -$268K
NBTB icon
138
NBT Bancorp
NBTB
$2.77B
$1.02M 0.15%
27,050
+20,337
+303% +$737K
IBP icon
139
Installed Building Products
IBP
$6.51B
$1.01M 0.15%
12,196
+9,284
+319% +$794K
MOD icon
140
Modine Manufacturing
MOD
$10.3B
$1.01M 0.15%
+95,973
New +$907K
LSCC icon
141
Lattice Semiconductor
LSCC
$18.2B
$1.01M 0.15%
20,788
+14,332
+222% +$714K
GTHX
142
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$1.01M 0.15%
+203,545
New +$1.13M
STKL
143
DELISTED
SunOpta
STKL
$1M 0.15%
129,161
+37,559
+41% +$247K
GD icon
144
General Dynamics
GD
$104B
$1M 0.15%
+4,536
New +$1.04M
CWK icon
145
Cushman & Wakefield Ltd
CWK
$3.29B
$1M 0.15%
65,746
+55,768
+559% +$981K
VIRT icon
146
Virtu Financial
VIRT
$5.16B
$1M 0.15%
42,759
+36,883
+628% +$1.06M
INSW icon
147
International Seaways
INSW
$4.49B
$996K 0.15%
46,970
-8,951
-16% -$197K
LLY icon
148
Eli Lilly
LLY
$1.04T
$995K 0.15%
3,069
-2,914
-49% -$875K
DAL icon
149
Delta Air Lines
DAL
$61.3B
$993K 0.15%
+34,263
New +$1.31M
COLB icon
150
Columbia Banking Systems
COLB
$8.87B
$990K 0.15%
+34,563
New +$1.02M
4 5
6
7 8

Similar funds

ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
SCI
S&CO Inc Boston, Massachusetts $1.61B AUM 21.39% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
BW
Browning West Los Angeles, California $1.62B AUM 22.28% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
PRA
Pine Ridge Advisers New York $1.62B AUM 16.97% 1-Year Est. Return
CC
Covalis Capital London, United Kingdom $1.63B AUM 27.84% 1-Year Est. Return

GSA Capital Partners's Q2 2022 Portfolio in Review

As of Q2 2022, GSA Capital Partners held 1,985 positions worth $666M, down 11% from $745M the previous quarter. Its ten largest holdings account for 3.7% of the portfolio.

GSA Capital Partners deployed $47.8M of net new capital in Q2 2022, opening 628 new positions and adding to 360 existing holdings. Its largest new stake was Relay Therapeutics: 178,593 shares worth $2.99M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Chicos FAS, Inc., an estimated $2.68M trimmed.

  • GSA Capital Partners's largest Q2 2022 buy was Relay Therapeutics: 178,593 shares worth $2.99M.
  • GSA Capital Partners added most to Genpact in Q2 2022, an estimated $2.6M increase.
  • GSA Capital Partners's biggest Q2 2022 reduction was Chicos FAS, Inc., cutting an estimated $2.68M.
  • GSA Capital Partners fully exited Amazon in Q2 2022, selling an estimated $3.07M.
  • GSA Capital Partners's ten largest holdings make up 3.7% of its $666M portfolio in Q2 2022.
  • GSA Capital Partners opened 628 new positions and closed 644 in Q2 2022.
  • GSA Capital Partners's portfolio value fell 11% quarter-over-quarter to $666M.

Based on GSA Capital Partners's 13F filing for Q2 2022, filed 9 Aug 2022.